UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

Movement disorders, 2019-02, Vol.34 (2), p.180-198

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options

Brain (London, England : 1878), 2021-10, Vol.144 (9), p.2571-2593

2021

Link zum Volltext

Verfügbarkeit prüfen

Parkinson disease-associated cognitive impairment

Nature reviews. Disease primers, 2021-07, Vol.7 (1), p.47-47, Article 47

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonmotor features of Parkinson's disease subtypes

Movement disorders, 2016-08, Vol.31 (8), p.1095-1102

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Parkinson's Disease Patients Affected by COVID‐19

Movement disorders, 2020-06, Vol.35 (6), p.905-908

2020

Link zum Volltext

Verfügbarkeit prüfen

Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features

Movement disorders, 2018-06, Vol.33 (6), p.909-919

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

Lancet neurology, 2009-05, Vol.8 (5), p.464-474

2009

Link zum Volltext

Verfügbarkeit prüfen

Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease

Neurobiology of disease, 2023-09, Vol.185, p.106237-106237, Article 106237

2023

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation

Journal of neurology, 2022-03, Vol.269 (3), p.1154-1163

2022

Link zum Volltext

Verfügbarkeit prüfen

The psychosis spectrum in Parkinson disease

Nature reviews. Neurology, 2017-02, Vol.13 (2), p.81

2017

Link zum Volltext

Verfügbarkeit prüfen

Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence

Brain, behavior, and immunity, 2021-11, Vol.98, p.59-73

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease

Movement disorders, 2018-03, Vol.33 (3), p.421-430

2018

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain

Journal of clinical pharmacology, 2016-07, Vol.56 (7), p.852-861

2016

Link zum Volltext

Verfügbarkeit prüfen

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

Alzheimer's & dementia, 2015-06, Vol.11 (6), p.608-621.e7

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapy of Parkinson’s Disease Subtypes

Neurotherapeutics, 2020-10, Vol.17 (4), p.1366-1377

2020

Link zum Volltext

Verfügbarkeit prüfen

Thirty years of research on autonomic dysfunction, non-motor features, and endophenotypes in Parkinson disease

Clinical autonomic research, 2021-02, Vol.31 (1), p.37-39

Chaudhuri, K. Ray

2021

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of keystroke dynamics as digital biomarkers for fine motor decline in neuropsychiatric disorders: a systematic review and meta-analysis

Scientific reports, 2022-05, Vol.12 (1), p.7690-7690, Article 7690

2022

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside

NPJ Parkinson's Disease, 2020, Vol.6 (1), p.18-18, Article 18

2020

Link zum Volltext

Verfügbarkeit prüfen

Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia

Neuropsychopharmacology (New York, N.Y.), 2013-05, Vol.38 (6), p.938-949

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of real life eating difficulties in Parkinson's disease patients by measuring plate to mouth movement elongation with inertial sensors

Scientific reports, 2021-01, Vol.11 (1), p.1632-1632, Article 1632

2021

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease

European journal of neurology, 2023-05, Vol.30 (5), p.1465-1480

2023

Link zum Volltext

Verfügbarkeit prüfen

Parkinson's disease symptoms: The patient's perspective

Movement disorders, 2010-08, Vol.25 (11), p.1646-1651

2010

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “Concerns Raised by Publication of Antonini et al., ‘Outcome of Parkinson Disease Patients Affected by Covid‐19’”

Movement disorders, 2020-08, Vol.35 (8), p.1298-1298

2020

Link zum Volltext

Verfügbarkeit prüfen

Unobtrusive detection of Parkinson's disease from multi-modal and in-the-wild sensor data using deep learning techniques

Scientific reports, 2020-12, Vol.10 (1), p.21370-21370, Article 21370

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.010

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(855)
Mit Volltextzugriff
(882)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options

Parkinson disease-associated cognitive impairment

Nonmotor features of Parkinson's disease subtypes

Outcome of Parkinson's Disease Patients Affected by COVID‐19

Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease

Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation

The psychosis spectrum in Parkinson disease

Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease

A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

Therapy of Parkinson’s Disease Subtypes

Thirty years of research on autonomic dysfunction, non-motor features, and endophenotypes in Parkinson disease

Diagnostic accuracy of keystroke dynamics as digital biomarkers for fine motor decline in neuropsychiatric disorders: a systematic review and meta-analysis

COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside

Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia

Assessment of real life eating difficulties in Parkinson's disease patients by measuring plate to mouth movement elongation with inertial sensors

Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease

Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

Parkinson's disease symptoms: The patient's perspective

Reply to: “Concerns Raised by Publication of Antonini et al., ‘Outcome of Parkinson Disease Patients Affected by Covid‐19’”

Unobtrusive detection of Parkinson's disease from multi-modal and in-the-wild sensor data using deep learning techniques

Suchergebnisse filtern